178 related articles for article (PubMed ID: 9564848)
1. Effect of interleukins on UGT2B15 and UGT2B17 steroid uridine diphosphate-glucuronosyltransferase expression and activity in the LNCaP cell line.
Lévesque E; Beaulieu M; Guillemette C; Hum DW; Bélanger A
Endocrinology; 1998 May; 139(5):2375-81. PubMed ID: 9564848
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation of two uridine diphospho-glucuronosyltransferases, UGT2B15 and UGT2B17, in human prostate LNCaP cells.
Guillemette C; Lévesque E; Beaulieu M; Turgeon D; Hum DW; Bélanger A
Endocrinology; 1997 Jul; 138(7):2998-3005. PubMed ID: 9202245
[TBL] [Abstract][Full Text] [Related]
3. Effect of fibroblastic growth factors (FGF) on steroid UDP-glucuronosyltransferase expression and activity in the LNCaP cell line.
Lévesque E; Beaulieu M; Guillemette C; Hum DW; Bélanger A
J Steroid Biochem Mol Biol; 1998 Jan; 64(1-2):43-8. PubMed ID: 9569009
[TBL] [Abstract][Full Text] [Related]
4. Characterization and regulation of UDP-glucuronosyltransferases in steroid target tissues.
Bélanger A; Hum DW; Beaulieu M; Lévesque E; Guillemette C; Tchernof A; Bélanger G; Turgeon D; Dubois S
J Steroid Biochem Mol Biol; 1998 Apr; 65(1-6):301-10. PubMed ID: 9699884
[TBL] [Abstract][Full Text] [Related]
5. Regulation of steroid glucuronosyltransferase activities and transcripts by androgen in the human prostatic cancer LNCaP cell line.
Guillemette C; Hum DW; Bélanger A
Endocrinology; 1996 Jul; 137(7):2872-9. PubMed ID: 8770908
[TBL] [Abstract][Full Text] [Related]
6. Characterization of UDP-glucuronosyltransferases active on steroid hormones.
Hum DW; Bélanger A; Lévesque E; Barbier O; Beaulieu M; Albert C; Vallée M; Guillemette C; Tchernof A; Turgeon D; Dubois S
J Steroid Biochem Mol Biol; 1999; 69(1-6):413-23. PubMed ID: 10419020
[TBL] [Abstract][Full Text] [Related]
7. UDP-glucuronosyltransferase 2B15 (UGT2B15) and UGT2B17 enzymes are major determinants of the androgen response in prostate cancer LNCaP cells.
Chouinard S; Barbier O; Bélanger A
J Biol Chem; 2007 Nov; 282(46):33466-33474. PubMed ID: 17848572
[TBL] [Abstract][Full Text] [Related]
8. Chromosomal localization, structure, and regulation of the UGT2B17 gene, encoding a C19 steroid metabolizing enzyme.
Beaulieu M; Lévesque E; Tchernof A; Beatty BG; Bélanger A; Hum DW
DNA Cell Biol; 1997 Oct; 16(10):1143-54. PubMed ID: 9364925
[TBL] [Abstract][Full Text] [Related]
9. Relative enzymatic activity, protein stability, and tissue distribution of human steroid-metabolizing UGT2B subfamily members.
Turgeon D; Carrier JS; Lévesque E; Hum DW; Bélanger A
Endocrinology; 2001 Feb; 142(2):778-87. PubMed ID: 11159850
[TBL] [Abstract][Full Text] [Related]
10. Multiple roles for UDP-glucuronosyltransferase (UGT)2B15 and UGT2B17 enzymes in androgen metabolism and prostate cancer evolution.
Gauthier-Landry L; Bélanger A; Barbier O
J Steroid Biochem Mol Biol; 2015 Jan; 145():187-92. PubMed ID: 24861263
[TBL] [Abstract][Full Text] [Related]
11. Calcitrol (1alpha,25-dihydroxyvitamin D3) inhibits androgen glucuronidation in prostate cancer cells.
Kaeding J; Bélanger J; Caron P; Verreault M; Bélanger A; Barbier O
Mol Cancer Ther; 2008 Feb; 7(2):380-90. PubMed ID: 18281521
[TBL] [Abstract][Full Text] [Related]
12. Forkhead box protein A1 regulates UDP-glucuronosyltransferase 2B15 gene transcription in LNCaP prostate cancer cells.
Hu DG; Mackenzie PI
Drug Metab Dispos; 2010 Dec; 38(12):2105-9. PubMed ID: 20736324
[TBL] [Abstract][Full Text] [Related]
13. Androgen-independent growth in LNCaP cell lines and steroid uridine diphosphate-glucuronosyltransferase expression.
Kanaya J; Takashima M; Koh E; Namiki M
Asian J Androl; 2003 Mar; 5(1):9-13. PubMed ID: 12646996
[TBL] [Abstract][Full Text] [Related]
14. Activators of the farnesoid X receptor negatively regulate androgen glucuronidation in human prostate cancer LNCAP cells.
Kaeding J; Bouchaert E; Bélanger J; Caron P; Chouinard S; Verreault M; Larouche O; Pelletier G; Staels B; Bélanger A; Barbier O
Biochem J; 2008 Mar; 410(2):245-53. PubMed ID: 17988216
[TBL] [Abstract][Full Text] [Related]
15. Alteration of human UDP-glucuronosyltransferase UGT2B17 regio-specificity by a single amino acid substitution.
Dubois SG; Beaulieu M; Lévesque E; Hum DW; Bélanger A
J Mol Biol; 1999 May; 289(1):29-39. PubMed ID: 10339403
[TBL] [Abstract][Full Text] [Related]
16. Estrogen regulation of the glucuronidation enzyme UGT2B15 in estrogen receptor-positive breast cancer cells.
Harrington WR; Sengupta S; Katzenellenbogen BS
Endocrinology; 2006 Aug; 147(8):3843-50. PubMed ID: 16690804
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of the androgen-conjugating UGT2B15 and UGT2B17 enzymes in prostate tumor cells during cancer progression.
Pâquet S; Fazli L; Grosse L; Verreault M; Têtu B; Rennie PS; Bélanger A; Barbier O
J Clin Endocrinol Metab; 2012 Mar; 97(3):E428-32. PubMed ID: 22170718
[TBL] [Abstract][Full Text] [Related]
18. Isoform-specific regulation of uridine diphosphate-glucuronosyltransferase 2B enzymes in the human prostate: differential consequences for androgen and bioactive lipid inactivation.
Chouinard S; Pelletier G; Bélanger A; Barbier O
Endocrinology; 2006 Nov; 147(11):5431-42. PubMed ID: 16887906
[TBL] [Abstract][Full Text] [Related]
19. Androgen glucuronidation: an unexpected target for androgen deprivation therapy, with prognosis and diagnostic implications.
Grosse L; Pâquet S; Caron P; Fazli L; Rennie PS; Bélanger A; Barbier O
Cancer Res; 2013 Dec; 73(23):6963-71. PubMed ID: 24121496
[TBL] [Abstract][Full Text] [Related]
20. Specificity of glucuronosyltransferase activity in the human cancer cell line LNCaP, evidence for the presence of at least two glucuronosyltransferase enzymes.
Guillemette C; Hum DW; Bélanger A
J Steroid Biochem Mol Biol; 1995 Dec; 55(3-4):355-62. PubMed ID: 8541232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]